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Abstract
Introduction Chronic obstructive pulmonary disease (COPD) is
a common cause of admission to intensive care units (ICUs) in
the UK. This report describes the case mix and outcomes of
these patients and explores associations of measures of case
mix available in the first 24 hours with outcome.
Method We conducted a secondary analysis of a high quality
clinical database, the ICNARC Case Mix Programme Database,
of 129,647 admissions to 128 adult, general critical care units
across England, Wales and Northern Ireland for the period from
1995 to 2001.
Results Nonsurgical admissions with COPD accounted for
3752 admissions (2.9% of all admissions). Patients were
acidotic (median pH 7.26, interquartile range [IQR] 7.18–7.33),
hypercapnic (median arterial CO2 tension 8.7, IQR 6.9–10.7)
and hypoxic (median arterial O2 tension/fractional inspired
oxygen gradient 22.9, IQR 17.2–29.6). Overall, 2775 (73.9%)
were definitely intubated and 278 (7.4%) were probably
intubated in the first 24 hours in the ICU. The median (IQR) ICU
length of stay was 4.0 (1.6–9.4) days and the hospital length of
stay was 16 (9–29) days. a total of 827 patients (23.1%) died
in the admitting ICU and 1322 (38.3%) died during hospital
admission. Age, presence of severe respiratory disease, length
of stay in hospital before critical care admission,
cardiopulmonary resuscitation within 24 hours before
admission, intubation status in first 24 hours in critical care, pH,
arterial oxygen tension/fractional inspired oxygen gradient,
albumin, cardiovascular organ failure, neurological organ failure
and renal organ failure all had independent associations with
hospital mortality. Respiratory organ failure had a significant
independent association with decreased hospital mortality.
Conclusion Nonsurgical patients with COPD represent an
important group of patients admitted to UK ICUs. The presence
of single organ respiratory failure in the first 24 hours in critical
care identifies patients with a 70% chance of surviving to leave
hospital.
Introduction
The prevalence of chronic obstructive pulmonary disease
(COPD) in the UK has been estimated to be 1%, increasing to
5% in men aged 65–74 years and 10% in men older than 75
years [1]. COPD accounted for more than 100,000 hospital
admissions in England in 2000/2001 and is the fifth most
common cause of mortality in the UK, with 30,000 deaths
each year [2]. Exacerbations of COPD may lead to respiratory
failure requiring ventilatory support either noninvasively or inva-
sively following endotracheal intubation. A recent UK study [3]
suggested that clinicians involved in the emergency care of
COPD patients had made a median of 10 intensive care unit
(ICU) gatekeeping decisions for COPD patients in the preced-
ing 12 months.
COPD is a progressive disorder that spans a continuum from
early mild disease to severe and disabling terminal disease,
and prognostic estimates can be important in informing critical
ADL = activities of daily living; APACHE = Acute Physiology and Chronic Health Evaluation; CI = confidence interval; CMP = Case Mix Programme; 
CMPD = Case Mix Programme Database; COPD = chronic obstructive pulmonary disease; FiO2 = fractional inspired oxygen; ICU = intensive care 
unit; IQR = interquartile range; PaO2 = arterial oxygen tension.
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care admission decisions [4]. Factors found to have an asso-
ciation with mortality have included those related to diminished
functional reserve resulting from the COPD, such as impair-
ments in activities of daily living (ADL) and factors related to
the aetiology of respiratory failure [5]; severity of the acute ill-
ness, measured using either the acute physiology score of
APACHE (Acute Physiology and Chronic Health Evaluation) II
[6] or APACHE III [5,7]; and the presence of nonrespiratory
organ failures [7,8].
The majority of studies reporting COPD ICU outcomes origi-
nate from the USA, and there have only been two recent stud-
ies from the UK; one reported on 42 intubated patients in a
single centre [9] and another reported hospital mortality of
277 COPD ICU admissions from 24 ICUs in one region of the
UK [10].
This report examines the outcomes of COPD patients admit-
ted to ICUs across England, Wales and Northern Ireland, iden-
tified using a high quality clinical database. The case mix at
ICU admission, outcome and activity associated with these
admissions are described. The effect of factors, determined a
priori, on hospital mortality is investigated.
Materials and methods
Case Mix Programme Database
Data were extracted for 129,647 admissions to 128 adult,
general critical care units (ICUs including combined intensive
care/high dependency units) from the Case Mix Programme
Database (CMPD), covering the period from December 1995
to August 2001. Data were collected locally by trained data
collectors according to precise rules and definitions, and the
data underwent extensive validation before incorporation into
the CMPD. The process of data validation and cleaning was
described in detail previously [11].
Selection of data
A standard coding method that classifies information describ-
ing the reasons for admission was used to identify the patients,
and has been described previously [12]. Surgical patients
were identified and excluded when the primary or secondary
reason for admission was a surgical code or if the patient was
admitted from theatre having undergone all or part of a surgical
procedure. Nonsurgical admissions were selected if they had
a primary reason for admission of COPD, exacerbation of
COPD or emphysema, or any of these three conditions as the
secondary reason for admission when pneumonia, right ven-
tricular failure, or left ventricular failure was the primary reason.
Patients were assigned to one of three subgroups of COPD
(pneumonia in a patient with COPD, right ventricular failure in
a patient with COPD, or left ventricular failure in a patient with
COPD) if the primary or secondary reason for admission was
pneumonia, right ventricular failure, or left ventricular failure,
respectively, in a patient in whom the other reason for admis-
sion was COPD, exacerbation of COPD, or emphysema. The
primary and secondary reasons for admission were the diag-
noses made by the clinicians and recorded in the patient
notes. As such the diagnoses were not arrived at by applying
preset diagnostic criteria but by using the working clinical
diagnoses reached during the management of the patients,
and will reflect the uncertainty inherent in clinical practice.
In addition, the intubation status of the COPD admissions was
categorized on the basis of whether they were definitely intu-
bated within the first 24 hours of admission to the Case Mix
Programme (CMP) unit, probably intubated in the first 24
hours, or not intubated in the first 24 hours. The CMPD does
not contain a response field solely for the identification of intu-
bation status, but patients with an intubated fractional inspired
oxygen (FiO2) recorded and those defined as intubated in the
field describing the intubation status associated with the low-
est arterial oxygen tension (PaO2) were identified as definitely
intubated. Patients who were probably intubated had a
response of 'yes' in the field for mechanical ventilation at
admission, or a non-zero value for the lowest or highest venti-
lated respiratory rate. Patients not intubated in the first 24
hours in the CMP unit fulfilled none of the above criteria.
Data
Data were extracted on case mix, outcome and activity for non-
surgical COPD admissions to CMP units. Detailed description
of the definitions used in the CMPD are described elsewhere
[11], but the definitions of particular relevance to the COPD
patients are outlined below.
Case mix
Age at admission and sex were extracted. A history of respira-
tory functional impairment and comorbidity was recorded
using data collected as part of the chronic health evaluation
section of the APACHE II score [13]. The respiratory func-
tional impairment has two aspects: 'severe respiratory dis-
ease' is defined as patients with permanent shortness of
breath with light activity due to pulmonary disease; and 'home
ventilation' specifies whether a patient has used or uses home
ventilation (excluding continuous positive airway pressure ven-
tilation). Patients with liver disease included those with an epi-
sode of hepatic encephalopathy in the previous 6 months or
who had evidence of portal hypertension. Patients with cardi-
ovascular comorbidity included patients with fatigue, claudica-
tion or angina at rest, in whom any activity increased the
symptoms and where the symptoms were ascribed to myocar-
dial or peripheral vascular disease. Patients with chronic renal
failure were those requiring chronic renal replacement therapy.
Patients with haematological diseases included those with
acute myelogenous leukaemia, acute lymphocytic leukaemia,
multiple myeloma, chronic myelogenous leukaemia, chronic
lymphocytic leukaemia, and lymphoma. Patients with immuno-
suppression included those with a congenital immunohumoral
or cellular immune deficiency state and those receiving chem-
otherapy defined as the receipt of a drug that can lower
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resistance to infection and those who have received radiother-
apy. AIDS patients were those meeting the current World
Health Organization definition. Patients with metastatic cancer
had distant metastases documented by surgery, imaging, or
biopsy. History of steroid treatment was defined as the receipt
of 0.3 mg/kg, or greater, prednisolone (or equivalent) daily for
the 6 months before critical care admission. Patients receiving
cardiopulmonary resuscitation within 24 hours before unit
admission were also identified.
The following physiological variables, selected a priori, were
extracted from the data collected during the first 24 hours in
the CMP unit: lowest pH; arterial carbon dioxide tension from
the arterial blood gas with the lowest pH; PaO2/FiO2 gradient
from the arterial blood gas with the lowest PaO2; and lowest
serum albumin. Organ failures were defined according to
Knaus [14] using data describing the patient's status during
the first 24 hours in the CMP unit. Acute severity was also
measured with the acute physiology scores from APACHE II
and APACHE III, and the APACHE II and APACHE III scores.
Outcome
Survival data were collected at discharge from the CMP unit
and at ultimate discharge from an acute hospital.
Activity
Length of stay in the CMP unit was calculated, as fraction of
days, from the date/time of admission to the CMP unit and
date/time of discharge from the CMP unit or death in the CMP
unit. Total length of stay in hospital was calculated, in days,
from the date of original admission to hospital and date of ulti-
mate discharge from hospital or death in hospital. Transfers in
from (out to) another critical care unit were identified as admis-
sions whose source of admission to the CMP unit (destination
following discharge from the unit) was any ICU or high
dependency unit in the same or another hospital. Readmis-
sions to the CMP unit in the same hospital stay were identified
from the postcode, date of birth and sex, and confirmed by the
participating units.
Analyses
The overall proportion of admissions to CMP units with non-
surgical COPD was calculated along with the proportion by
subgroups: COPD with pneumonia; COPD with right ventricu-
lar failure; and COPD with left ventricular failure. Case mix,
outcome and activity were described for the overall group and
for the subgroups. Admissions of patients younger than 16
years, admissions of patients who stayed for less than 8 hours
in critical care, and readmissions within the same hospital stay
and transfers from other ICUs were excluded from the calcula-
tion of the APACHE II acute physiology score and APACHE II
score. Admissions of patients younger than 16 years, admis-
sions of patients who stayed fewer than 4 hours in critical care,
and readmissions within the same hospital stay were excluded
from the calculation of the APACHE III acute physiology score
and APACHE III score.
The effects of case mix factors, specified a priori, on ultimate
hospital mortality for nonsurgical admissions with COPD were
investigated using logistic regression.
Readmissions within the same hospital stay and admissions
for whom hospital outcome data were missing were excluded
from all analyses relating case mix factors to ultimate hospital
mortality. In addition to univariate analyses, the factors were
entered into a multiple logistic regression model. Adjusted
subgroup effects were calculated for the three specified sub-
groups from the multiple logistic regression model.
All analyses were performed using Stata 8.0 (StataCorp, Col-
lege Station, TX, USA).
Results
Case mix
Of 129,647 admissions to 128 adult, general critical care
units in the CMPD, 3755 (2.9%) of admissions were identified
as nonsurgical COPD patients. Table 1 describes measures of
case mix for all patients with COPD and the subgroups with
pneumonia, right ventricular failure and left ventricular failure.
Overall, 35% of patients had severe respiratory disease before
hospital admission and 9% had received daily steroids in the
6 months before admission, although only 2% were receiving
home ventilation. Comorbidity was relatively rare, with fewer
than 1% of patients having any comorbidity other than cardio-
vascular disease, and with cardiovascular comorbidity present
in 2.2% of the group as a whole, 5.9% of those with right ven-
tricular failure and 7.6% of those with left ventricular failure.
Patients spent a median of 1 day in hospital before admission
to the CMP unit, and 8.3% of patients received CPR in the 24
hours before admission to the CMP unit. Of the group as a
whole, 2775 (73.9%) were definitely intubated in the first 24
hours, with an additional 278 (7.4%) probably intubated in the
first 24 hours. Patients were acidotic, hypercapnic and
hypoxic, and had low serum albumin (Table 1). For the group
as a whole the median (interquartile range [IQR]) APACHE II
and APACHE III scores were 18 (14–23) and 62 (49–78),
respectively. Of all admissions, 12.2% had no organ failures,
49.4% had single organ failure (the majority, 45.2% of all
admissions, being respiratory), 27.6% had two organ failures,
and had 8.2% three or more organ failures.
Outcome and activity
Overall, 827 (23.1%) patients died in the admitting CMP unit
and 1322 (38.3%) died during the hospital admission (Table
2). The median (IQR) length of stay in the CMP unit was 4.0
(1.6–9.4) days and in hospital it was 16 (9–29) days.
Readmissions within the same hospital stay accounted for
4.5% of all admissions. A decision was made to withdraw all
active treatment in 422 (11.3%) patients, with the withdrawal
Critical Care    Vol 9 No Suppl 3    Wildman et al.
S41
Table 1
Case mix for admissions with chronic obstructive pulmonary disease by subgroup
All (n = 3752) I. Pneumonia (n = 775) II. Right VF (n = 147) III. Left VF (n = 142)
Age (years; median [IQR]) 67.8 (60.5–73.6) 68.7 (61.4–74.0) 68.8 (61.7–74.0) 71.9 (67.2–75.1)
Sex (n [%] male) 1942 (51.8) 401 (51.7) 83 (56.5) 81 (57.0)
Past medical history (n [%])
Respiratory impairment
Severe respiratory disease 1236 (35.0) 232 (31.6) 57 (42.2) 33 (25.2)
Home ventilation 70 (2.0) 6 (0.8) 6 (4.4) 2 (1.5)
Steroid treatment 305 (8.6) 61 (8.3) 7 (5.2) 8 (6.1)
Comorbidity:
Liver disease 6 (0.2) 3 (0.4) 0 (0.0) 0 (0.0)
Cardiovascular disease 79 (2.2) 11 (1.5) 8 (5.9) 10 (7.6)
Chronic renal failure 11 (0.3) 1 (0.1) 0 (0.0) 0 (0.0)
Immunosuppression 27 (0.4) 3 (0.1) 1 (0.7) 1 (0.8)
Metastatic cancer 6 (0.5) 1 (0.4) 0 (0.0) 0 (0.0)
Hospital stay prior to unit admission (days; 
median [IQR])
1 (0–3) 1 (0–3) 1 (0–2) 0 (0–2)
CPR prior to admission (n [%])a 308 (8.3) 45 (5.8) 20 (13.8) 12 (8.5)
Intubation status (n [%])b
Definitely intubated 2774 (73.9) 605 (78.1) 104 (13.8) 103 (72.5)
Probably intubated 278 (7.4) 56 (7.2) 13 (8.8) 9 (6.3)
Not intubated 700 (18.7) 114 (14.7) 30 (20.4) 30 (21.2)
Physiologyb
Lowest pH (median [IQR]) 7.26 (7.18–7.33) 7.26 (7.18–7.33) 7.25 (7.19–7.33) 7.24 (7.15–7.32)
PaCO2 (kPa; median [IQR])c 8.7 (6.9–10.7) 8.6 (6.9–10.6) 9.1 (7.2–11.7) 7.6 (6.4–10.4)
PaO2/FiO2 gradient (kPa; median [IQR])d 22.9 (17.2–29.6) 21.2 (15.3–27.8) 20.9 (17.2–26.2) 23.3 (15.9–29.3)
Lowest serum albumin (g/l; median [IQR]) 28 (23–33) 26 (21–31) 28 (25–32) 30 (25–34)
APACHE II
APS (mean [SD]) 13.4 (5.6) 14.3 (5.5) 13.5 (5.1) 14.6 (6.2)
APS (median [IQR]) 12 (10–16) 13 (10–17) 13 (10–17) 14 (10–18)
Score (mean [SD]) 19.4 (6.4) 20.3 (6.3) 19.9 (5.8) 20.7 (6.8)
Score (median [IQR]) 19 (15–23) 19 (16–23) 19 (16–24) 20 (16–24)
APACHE III
APS (mean [SD]) 52.9 (21.5) 55.9 (21.6) 53.4 (20.0) 56.8 (21.5)
APS (median [IQR]) 50 (39–64) 52 (42–68) 53 (41–66) 55 (42–68)
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decision being made a median (IQR) of 3.7 (1.2–7.9) days
after admission to the CMP unit. The 2765 patients who were
definitely intubated in the first 24 hours in the CMP unit had a
median (IQR) stay in the CMP unit of 5.7 (2.5–11.4) days, as
compared with 1.3 (0.6–2.6) days for the 697 patients who
were definitely not intubated in the first 24 hours (Table 3).
Risk factors for hospital mortality
Patients without any organ failure had a hospital mortality
(95% confidence interval [CI]) of 33.8% (29.4–38.4%)
whereas patients with single organ respiratory failure had a
hospital mortality of 29.8% (27.6–32.1%; Table 4). As the
number of organ failures increased the hospital mortality
increased, with patients who had respiratory failure and three
additional organ failures having a hospital mortality of 83.3%
(65.3–94.4%). Eleven characteristics were found to have a
significant independent association with increased hospital
mortality in the multivariate analysis (Table 5): increased age;
presence of severe respiratory disease; increased length of
stay in hospital before admission to the CMP unit; cardiopul-
monary resuscitation within 24 hours before admission; intu-
bation status in the first 24 hours in the CMP unit; low pH; low
PaO2/FiO2 gradient; low serum albumin; cardiovascular organ
failure; neurological organ failure; and renal organ failure. Res-
piratory organ failure had a significant independent associa-
tion with decreased hospital mortality (Table 5).
Case mix adjusted comparison of the three subgroups pneu-
monia, right ventricular failure and left ventricular failure gave
adjusted odds ratios for ultimate hospital mortality (95% CI) of
1.04 (0.86–1.27), 1.59 (1.06–2.38) and 0.77 (0.50–1.18),
respectively. This showed patients with right ventricular failure
to have a significantly increased risk for hospital mortality after
case mix adjustment.
Discussion
This study describes the outcomes of 3752 COPD patients
admitted to UK ICUs over a 5-year period and includes analy-
ses that describe the association between patient characteris-
tics available within the first 24 hours of ICU admission and
hospital outcome.
Overall, patients with COPD admitted to the 128 ICUs in this
study had a 77% chance of surviving to leave ICU and a 61%
chance of surviving to leave hospital. Comparisons of ICU
outcomes between studies are difficult to interpret because
ICU beds are used in different ways in different countries and
subtle differences in inclusion criteria can make populations
differ in prognostically important ways. The SUPPORT (Study
to Understand Prognoses and Preferences for Outcomes and
Risks of Treatment) study [5] recruited consecutive
hypercapnic COPD patients admitted to five US hospitals. Of
the 1016 hospitalized hypercapnic COPD patients, 526
(51.8%) were admitted to ICU and 348 (66.2%) of those
admitted to the ICU were intubated. This intubation rate con-
trasts with 81.1% being probably or definitely intubated in the
first 24 hours in the present study. Caution must also be exer-
cised in comparisons focusing on the apparently more homo-
geneous intubated groups. For example, although the study
conducted by Seneff and coworkers [7] included patients with
COPD exacerbations, patients who had right ventricular failure
or pneumonia were excluded. In our study, patients with right
ventricular failure had a significant, independent increased risk
for death, and the exclusion of these patients may go some
way to explaining the difference in hospital mortality in intu-
bated patients between the Seneff study (31.8%, 95% CI
24.8–39.3%) and this study (40.6%, 95% CI 38.8–42.3%).
Although almost all studies report hospital mortality, measures
such as 30- or 60-day mortality are more robust for compari-
son purposes because the definition of hospital mortality may
be influenced by local discharge practices. For example, Nev-
ins and Epstein [6] reported a comparatively low hospital mor-
tality of 27.7% (95% CI 21.1–35.2%) in 166 intubated COPD
patients from one US centre, but 38% of patients were trans-
ferred to chronic care facilities. In contrast, Ely and coworkers
[15] reported a hospital mortality of 38.6% (95% CI 24.4–
Score (mean [SD]) 65.9 (23.0) 69.3 (23.0) 66.6 (21.8) 71.6 (22.9)
Score (median [IQR]) 63 (50–78) 66 (54–83) 66 (52–80) 69.5 (55–84)
Organ system failures (n [%])
0 457 (12.2) 85 (11.0) 19 (12.9) 15 (10.6)
1 Respiratory 1767 (45.2) 362 (45.0) 56 (37.4) 55 (33.8)
1 Other 214 (4.4) 60 (9.3) 5 (4.1) 9 (8.5)
2 1036 (27.6) 215 (27.7) 50 (34.0) 50 (35.2)
3 or more 309 (8.2) 54 (7.0) 17 (11.6) 17 (12.0)
aDuring 24 hours before unit admission. bDuring first 24 hours following unit admission. cTaken from ABG with lowest pH. d Taken from ABG with 
lowest PaO2. ABG, arterial blood gas; APACHE, Acute Physiology and Chronic Health Evaluation; APS, Acute Physiology Score; CPR, 
cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; IQR, interquartile range; PaO2, arterial carbon dioxide tension; PaO2, arterial oxygen 
tension; SD, standard deviation; VF, ventricular failure.
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54.5%) for 44 intubated COPD patients from a US academic
centre, which is similar to that observed in the present study.
Esteban and coworkers [16] studied 522 patients with COPD
receiving mechanical ventilation in 361 ICUs in 20 countries
and found an overall hospital mortality of 28% (95% CI 24–
32%) with a median (IQR) Simplified Acute Physiology Score
II of 38 (31–49), as compared with 42 (35–52) for the intu-
bated patients in the present study.
Differences in length of stay between studies are likely to be
influenced by the case mix and supply side factors discussed
above. The 522 mechanically ventilated COPD patients from
the study by Esteban and coworkers [16] had a median (IQR)
length of ICU stay of 8 (5–13) days, as compared with 4.0
(1.6–9.4) days observed in our study. However, the total hos-
pital length of stay was similar in both studies, with the Este-
ban study having a median (IQR) hospital stay of 17 (10–27)
days versus 16 (9–29) days in the present study. Longer ICU
stay (median 7 days, IQR 4–14) and similar hospital stay
(median 14 days, IQR 9–29) are also apparent in the study by
Nevins and Epstein [6]. The greater proportion of the total hos-
pital stay spent in European and North American ICUs com-
pared with the UK may well reflect the lower proportion of all
hospital beds designated for critical care in the UK.
This study demonstrates that age has an independent relation-
ship with hospital death. This increased risk is similar to that
observed in the SUPPORT study, which calculated the inde-
pendent relative hazard of death to be 1.22 (95% CI 1.05–
1.41) per 10-year increase [5]. A number of studies of COPD
outcome [6,8,9,17] did not find a relationship between age
and hospital mortality. There is potential for prognostic studies
to produce conflicting results because of inaccuracy in the
measurement of patient characteristics, inadequate measure-
ment of and adjustment for confounding, and lack of power
[18,19]. Most commentators suggest that a minimum of
between 15 and 20 deaths will be required per risk factor ana-
lyzed [20,21]. In three of the studies that did not find age to
predict mortality [6,8,9], age was analyzed as a univariate pre-
dictor with between 20 and 46 deaths. In the study by Breen
and coworkers [17], in which age was analyzed in a multivari-
ate logistic regression, there were only 15 hospital deaths.
Of chronic diseases existing before hospitalization, only
severe respiratory disease had a significant independent rela-
tionship with hospital death. Patients with severe respiratory
disease have shortness of breath performing most ADL, and
the increased risk for mortality for patients with severe respira-
tory disease is consistent with the increased hazard of death
associated with impairment in ADL identified in SUPPORT
(relative hazard per additional ADL impairment: 1.14, 95% CI
1.03–1.26) [5]. Prior cardiovascular disease was only present
in 78 patients (2% of the total) and did not have a significant
independent association with outcome. Although a 2% preva-
lence of cardiovascular comorbidity may seem surprisingly low
in a COPD population, it is should be remembered that, to
qualify for this comorbidity, patients had to have impairment
equivalent to New York Heart Association functional class IV.
A total of 294 patients (7.8%) had received 0.3 mg/kg steroid
daily for the 6 months prior to admission. Oral steroids have
Table 2
Outcome and activity for admissions with chronic obstructive pulmonary disease by subgroup
All (n = 3752) I. Pneumonia (n = 775) II. Right VF (n = 147) III. Left VF (n = 142)
Outcome
Mortality in the CMP unit (n [%]) [95% CI] 827 (23.1) [21.7–24.5] 183 (24.5) [21.5–27.8] 50 (34.7) [27.0–43.1] 33 (24.1) [17.2–32.1]
Mortality in any hospital (n [%]) [95% CI]a 1322 (38.3) [36.7–40.0] 288 (40.1) [36.5–43.8] 73 (51.4) [42.9–59.9] 47 (36.4) [28.1–45.4]
Activity
Length of stay
In CMP unit (days; median [IQR]) 4.0 (1.6–9.4) 5.5 (2.2–11.8) 4.1 (1.4–9.1) 3.3 (1.2–7.3)
Any hospital (days; median [IQR])a 16 (9–29) 19 (10–33) 13 (6–22) 14 (8–27)
Readmission within same hospital stay (n [%]) 169 (4.5) 29 (3.7) 3 (2.0) 5 (3.5)
Transferred in (n [%])b 529 (14.1) 144 (18.6) 10 (6.9) 19 (13.5)
Transferred out (n [%])b,c 537 (18.6) 133 (22.7) 11 (11.3) 18 (17.0)
Decision made to withdraw all active treatment (n [%]) 422 (11.3) 88 (11.4) 31 (21.1) 16 (11.3)
Time from unit admission to treatment withdrawal (days; 
median [IQR])d
3.7 (1.2–7.9) 5.0 (1.8–9.2) 4.0 (1.0–9.0) 3.0 (1.1–7.6)
Time from treatment withdrawal to death(hours; median [IQR])e 3.3 (1.1–8.9) 3.3 (1.0–9.4) 4.3 (1.5–7.6) 3.9 (2.0–6.8)
aExcluding 169 (4.5%) admissions who were readmissions to the intensive care unit (ICU) within the same hospital stay. bFrom/to another critical 
care unit. cPercentage of patients who were discharged from the unit alive. dCalculated on all admissions with a decision to withdraw active 
treatment. eCalculated on all admissions with a decision to withdraw active treatment, excluding 32 (7.6%) who were discharged from the unit alive. 
CI, confidence interval; CMP, Case Mix Programme; IQR, interquartile range; VF, ventricular failure.
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been suggested to confer an increased risk for hospital mor-
tality in a small study conducted in intubated COPD patients
using univariate analysis [9]. It is possible that the lack of asso-
ciation of oral steroids with death in this study may represent
a true absence of association. However, the use of oral ster-
oids in a heterogeneous population, which might have
included both COPD patients with a marked asthmatic com-
ponent and a better than average prognosis, as well as very
severe COPD patients with a worse than average prognosis,
could lead to no net effect being detected, as of course could
incomplete documentation of steroid use in the population as
a whole.
In a study of 362 COPD admissions to US critical care units
[22] the number of days in hospital before critical care admis-
sion was reported to be significantly associated with hospital
mortality, although the increased risk per day was not
reported. This study confirms an association between days in
hospital before ICU and hospital mortality, but it shows the
independent risk to be relatively small with patients having only
a 2% (95% CI 1–3%) increased odds of hospital death for
each day in hospital before ICU admission.
Brochard and coworkers [23] suggested that invasive ventila-
tion was associated with increased mortality when compared
with noninvasive ventilation, but there were differences in
severity between groups. Seneff and coworkers [7] found that
intubation on day 1 was not an independent predictor of hos-
pital mortality (P = 0.07) in a multiple regression model, with
170 patients intubated on day 1 and 54 deaths among intu-
bated patients. Afessa and coworkers [8] also failed to find an
independent association between intubation and death in a
study of 250 episodes of respiratory failure in 180 COPD
patients, in which 153 patients episodes involved intubation
and 31 patients died. In this study, 3052 patients were defi-
nitely or probably intubated on day 1 and intubation on day 1
was associated with an independent odds ratio (95% CI) of
1.36 (1.07–1.73) for hospital mortality. Given that the risk for
ventilator-associated pneumonia has been estimated to be 3%
per day [24], it would not be surprising to find increased hos-
pital mortality associated with intubation, and it is possible that
the Seneff and Afessa studies were underpowered to detect
this effect.
Cardiovascular, neurological and renal organ failures were all
associated with a significant, independent increased risk for
hospital mortality. Treatment withdrawal was reported to occur
in 11.3% of admissions, and if the development of organ fail-
ure were to precipitously trigger withdrawal decisions then
interpretation of the prognosis associated with organ failure
would be difficult. Treatment withdrawal was most common in
patients with acute renal failure, but treatment withdrawal
accounted for fewer than one-third of the deaths, and recalcu-
lation of the risk for death after removing all patients with with-
drawal decisions resulted in little change in the OR for death
associated with acute renal failure. Respiratory organ failure
had a significant independent association with lower hospital
mortality, with patients with isolated respiratory failure having
a hospital mortality of 29.8%, as compared with 33.8% for
patients without any organ failures. It is possible that patients
admitted to ICU with COPD but without respiratory organ fail-
ure had more severe illness in other organ systems. For exam-
ple, although the regression model adjusts for the presence or
absence of acute renal failure, the severity of renal failure may
still constitute residual confounding. Afessa and coworkers [8]
also used the Knaus organ failure classification [14] and found
an independent increased odds of hospital death of 5.5 per
organ failure (excluding respiratory organ failure). Seneff and
coworkers [7] found that the development of nonrespiratory
organ dysfunction was the major predictor of hospital mortality
in 362 COPD admissions to US ICUs. This is also consistent
with a study of patients with heterogeneous causes of respira-
Table 3
Length of stay in the Case Mix Programme unit by patient 
factors
n Length of stay (days; 
median [IQR])
Age>
<55 484 3.6 (1.6–8.9)
55–60 410 4.7 (1.9–9.6)
60–64 574 4.1 (1.7–9.5)
65–69 761 4.5 (1.9–9.6)
70–74 785 4.2 (1.6–10.7)
75–79 557 3.0 (1.0–7.2)
80+ 167 3.1 (1.3–7.2)
CPR before admissiona
No 3411 4.1 (1.6–9.5)
Yes 307 3.5 (1.1–8.8)
Intubation statusb
Not intubated 697 1.3 (0.6–2.6)
Probably intubated 276 2.0 (0.8–5.4)
Definitely intubated 2765 5.7 (2.5–11.4)
Organ system failures
None 454 2.5 (1.0–7.6)
1 Respiratory 1688 4.0 (1.9–9.4)
1 Other 251 3.3 (1.0–8.6)
2 1036 5.1 (2.0–10.6)
3+ 309 2.2 (0.8–7.5)
aDuring 24 hours prior to unit admission. bDuring first 24 hours 
following unit admission. CPR, cardiopulmonary resuscitation; IQR, 
interquartile range.
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Table 4
Ultimate hospital mortality by organ system failures
Organ system failures n Mortality (95% CI)
None 441 33.8 (29.4–38.4)
1 Respiratory 1632 29.8 (27.6–32.1)
1 Other 244 45.9 (39.5–52.4)
2 991 43.8 (40.7–46.9)
3+ 303 70.0 (64.5–75.1)
CI, confidence interval.
Table 5
Multiple logistic regression model of patient factors in relation to ultimate hospital mortality
Deaths n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI)
Age 1.59 (1.46 – 1.73) 1.57 (1.44 – 1.73)
<55 103 469 (22.0) per 10 year increase per 10 year increase
55 – 60 108 395 (27.3)
60 – 64 187 556 (33.6)
65 – 69 281 745 (37.7)
70 – 74 325 747 (43.5)
75 – 79 293 537 (54.6)
80+ 96 162 (59.3)
Sex
Female 630 1742 (36.2) Ref. Ref
Male 763 1869 (40.8) 1.19 (1.03 – 1.39) 1.04 (0.88 – 1.22)
Severe respiratory disease
No 827 2204 (37.5) Ref. Ref.
Yes 487 1200 (40.6) 1.15 (0.98 – 1.34) 1.23 (1.03 – 1.46)
Home ventilation
No 1288 3337 (38.6) Ref. Ref.
Yes 26 67 (38.8) 1.05 (0.62 – 1.78) 1.16 (0.65 – 2.07)
Steroid treatment in previous 6 months
No 1204 3110 (38.7) Ref. Ref.
Yes 110 294 (37.4) 0.96 (0.74 – 1.24) 1.00 (0.75 – 1.33)
Comorbidity: liver disease
No 1309 3398 (38.5) Ref. Ref.
Yes 5 6 (83.3) 8.22 (0.96 – 70.47) 3.70 (0.39 – 35.37)
Comorbidity: cardiovascular disease
No 1282 3326 (38.5) Ref. Ref.
Yes 32 78 (41.0) 1.03 (0.63 – 1.68) 0.88 (0.51 – 1.50)
Comorbidity: chronic renal failure
No 1306 3393 (38.5) Ref. Ref.
Yes 8 11 (72.7) 3.29 (0.82 – 13.17) 2.21 (0.50 – 9.77)
Comorbidity: immunosuppression
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No 1299 3377 (38.5) Ref. Ref.
Yes 15 27 (55.6) 1.92 (0.89 – 4.17) 1.75 (0.71 – 4.28)
Comorbidity: metastatic cancer
No 1310 3398 (38.6) Ref. Ref.
Yes 4 6 (66.7) 3.28 (0.60 – 17.96) 2.50 (0.43 – 14.66)
Length of stay before unit admission (days) 1.02 (1.01 – 1.03) 1.02 (1.01 – 1.03)
0 567 1618 (35.0) per 1 day increase per 1 day increase
1 256 753 (34.0)
2 111 282 (39.4)
3+ 449 927 (48.4)
CPR within 24 hours before admission
No 1207 3291 (36.7) Ref. Ref.
Yes 176 301 (58.5) 2.38 (1.83 – 3.08) 1.83 (1.37 – 2.45)
Intubation statusa
Not intubated 206 684 (30.1) Ref. Ref.
Definitely/probably intubated 1187 2927 (40.6) 1.71 (1.38 – 2.13) 1.36 (1.07 – 1.73)
Lowest pHa 1.31 (1.23 – 1.40) 1.23 (1.13 – 1.35)
<7.18 391 758 (51.6) per 0.1 decrease per 0.1 decrease
7.18–7.25 294 797 (36.9)
7.26–7.32 259 815 (31.8)
= 7.33 297 877 (33.9)
PaCO2 from ABG with lowest pH (kPa)a 1.09 (0.91 – 1.29) 1.01 (0.79 – 1.29)
<6.9 334 784 (42.6) per 10 kPa increase per 10 kPa increase
6.9–8.6 316 836 (37.8)
8.7–10.6 270 783 (34.5)
= 10.7 320 843 (38.0)
PaO2/FiO2 gradient (kPa)a 1.17 (1.09 – 1.26) 1.13 (1.04 – 1.22)
<17.2 425 871 (48.8) per 10 kPa decrease per 10 kPa decrease
17.2–22.8 300 860 (34.9)
22.9–29.5 293 856 (34.2)
= 29.6 294 852 (34.5)
Lowest albumin (g/l)a
<20 178 303 (58.8) 2.73 (2.11 – 3.54) 1.94 (1.46 – 2.58)
20–24 208 477 (43.6) 1.49 (1.20 – 1.84) 1.28 (1.01 – 1.61)
= 25 or not recorded 1007 2831 (35.6) Ref. Ref.
Organ system failure: respiratory
No 335 786 (42.6) Ref. Ref.
Yes 1058 2825 (37.5) 1.09 (0.87 – 1.36) 0.71 (0.55 – 0.91)
Organ system failure: cardiovascular
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tory failure [25], in which other organ failures were found to be
more important than the severity of the respiratory failure.
Although practice may have changed over the period during
which data were sampled, for example because increasing use
of noninvasive ventilation, this analysis was not conceived to
explore, detect and report secular trends. This may be a suita-
ble topic for further research in this area.
When patients with obstructive lung disease present with
decompensated type II respiratory failure, it can be very diffi-
cult to distinguish those with 'pure' COPD (without any signif-
icant reversibility) from those with a mixture of COPD and
asthma (patients with a major component of fixed obstruction
that coexists with some reversibility). It is likely that patients
with greater reversibility will tend to be younger, possibly
respond better to steroids and have a better overall prognosis.
Unfortunately, the CMP data do not allow this distinction to be
explored, and there is no real agreement about how this dis-
tinction should be made even when a patient has had full lung
function – a distinction that is even harder in the acute setting
when information regarding lung function is rarely available.
Additional prospective research may be required to further illu-
minate this problem.
Conclusion
This study demonstrates that patients admitted to ICU with
COPD and single organ respiratory failure have a 70% chance
of leaving hospital alive and a median length of stay in hospital
of 16 days. Although patients entering critical care will repre-
sent a selected group of all those patients admitted to hospital
with respiratory failure, it is reassuring that the independent
risk factors for mortality have much in common with those
identified in the SUPPORT cohort, which included all COPD
admissions with hypercapnic respiratory failure irrespective of
whether the patient was admitted to ICU.
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No 881 2594 (34.0) Ref. Ref.
Yes 512 1017 (50.3) 2.21 (1.87 – 2.62) 1.48 (1.22 – 1.79)
Organ system failure: neurological
No 1066 2978 (35.8) Ref. Ref.
Yes 327 633 (51.7) 1.85 (1.53 – 2.24) 1.36 (1.10 – 1.68)
Organ system failure: renal
No 1190 3346 (35.6) Ref. Ref.
Yes 203 265 (76.6) 5.17 (3.70 – 7.23) 3.83 (2.67 – 5.47)
Organ system failure: haematological
No 1362 3550 (38.4) Ref. Ref.
Yes 31 61 (50.8) 1.65 (0.94 – 2.89) 1.30 (0.69 – 2.45)
Ultimate hospital mortality excludes admissions who were readmissions to the intesnive care unit within the same hospital stay, admissions whose 
ultimate hospital discharge status was missing, and admissions for whom any of the entered risk factors were missing. aDuring first 24 hours 
following unit admission. ABG, arterial blood gas; CI, confidence interval; CPR, cardiopulmonary resuscitation; FiO2, fractional inspired oxygen; OR, 
odds ratio; PaCO2, arterial carbon dioxide tension; PaO2, arterial oxygen tension.
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Key messages
• Non-surgical COPD patients account for 2.9% of all 
ICU admissions in the UK
• Intubated patients have a median stay in intensive care 
of 6 days
• COPD patients admitted to ICU have a mortality of 23% 
in the admitting ICU and 38% in hospital, which is simi-
lar to the mortality of patients with all diagnoses admit-
ted to ICU
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